Curated News
By: NewsRamp Editorial Staff
May 09, 2024
Millions of Americans Living with Alzheimer's: New Treatment Options on the Horizon
TLDR
- Otsuka’s Rexulti and IGC Pharma's IGC-AD1 are potential treatments for Alzheimer's disease, providing a competitive advantage in addressing the symptoms and underlying causes of the condition.
- Otsuka’s Rexulti and IGC Pharma's IGC-AD1 are being researched as potential treatments for Alzheimer's disease by affecting neurotransmitters in the brain and targeting neuroinflammation and CB1 receptor dysfunction, respectively.
- Otsuka’s Rexulti and IGC Pharma's IGC-AD1 offer hope for millions of Americans affected by Alzheimer's disease, aiming to alleviate agitation and provide safe and effective therapy without major black box warnings.
- IGC Pharma's IGC-AD1, containing THC as one of two active pharmaceutical agents, is undergoing extensive clinical trials to evaluate its effectiveness and safety in treating Alzheimer's disease, showing promising results in reducing agitation levels.
Impact - Why it Matters
The development of potential treatments for Alzheimer's and Agitation in Alzheimer's Disease (AAD) could provide hope for millions of Americans who have family members with AD or are worried about developing AD later in life. If successful, these treatments could offer a simpler and faster treatment option for patients without major black box warnings, impacting the emotional and financial cost to patients and caregivers.
Summary
Over 6.7 million Americans aged 65 and older are living with Alzheimer’s disease (AD), a number predicted to grow to 13.8 million by 2060. A lesser-known subsection of Alzheimer’s patients, despite a 40%-80% prevalence in the patient population, suffer from Agitation in Alzheimer’s Disease (AAD). Currently, there is no perfect treatment for AD or AAD. Otsuka’s Rexulti and IGC Pharma's IGC-AD1 are being explored as potential treatments, with IGC-AD1 showing promising results in a Phase 2 clinical trial.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Millions of Americans Living with Alzheimer's: New Treatment Options on the Horizon
